These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9409497)

  • 61. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Physical activity in individuals with haemophilia and experience with recombinant factor VIII Fc fusion protein and recombinant factor IX Fc fusion protein for the treatment of active patients: a literature review and case reports.
    Wang M; Álvarez-Román MT; Chowdary P; Quon DV; Schafer K
    Blood Coagul Fibrinolysis; 2016 Oct; 27(7):737-744. PubMed ID: 27116081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of haemophilia.
    Ludlam CA
    Br J Haematol; 1998 May; 101 Suppl 1():13-4. PubMed ID: 9607736
    [No Abstract]   [Full Text] [Related]  

  • 64. High cost patients and the consortium approach.
    Schonfield S; Reid K
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():26-8. PubMed ID: 12214143
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preventing bleeds by treatment: new era for haemophilia changing the paradigm.
    Marijke van den Berg H
    Haemophilia; 2016 Jul; 22 Suppl 5():9-13. PubMed ID: 27405669
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hemophilia Gene Therapy: Ready for Prime Time?
    VandenDriessche T; Chuah MK
    Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Haemophilia treatment centres in Germany].
    Zimmermann R; Eifrig B; Lenk H; Pollmann H; Scharrer I; Huth-Kühne A
    Hamostaseologie; 2012; 32 Suppl 1():S12-9. PubMed ID: 22960780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry.
    Fischer K; Ljung R; Platokouki H; Liesner R; Claeyssens S; Smink E; van den Berg HM
    Haemophilia; 2014 Jul; 20(4):e280-6. PubMed ID: 24784937
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B.
    Wang C; Young G
    Haemophilia; 2018 May; 24(3):414-419. PubMed ID: 29405496
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Home treatment in hemophilia].
    Pabinger I; Niessner H; Korninger C; Nowotny C; Stain M; Kyrle PA; Lechner K
    Wien Klin Wochenschr; 1987 Nov; 99(22):773-7. PubMed ID: 3124354
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HIV-1 infection in haemophilia.
    Madhok R; Forbes CD
    Baillieres Clin Haematol; 1990 Jan; 3(1):79-101. PubMed ID: 2108739
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Haemophilia part 1: an introduction.
    Khair K
    Br J Nurs; 2013 Jun 13-26; 22(11):620. PubMed ID: 23899729
    [No Abstract]   [Full Text] [Related]  

  • 74. Inhibitor economics.
    Teitel J
    Semin Hematol; 2006 Apr; 43(2 Suppl 4):S14-7. PubMed ID: 16690371
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.
    Miller CH
    Haemophilia; 2018 Mar; 24(2):186-197. PubMed ID: 29446525
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survey of coagulation factor concentrates tender and procurement procedures in 38 European Countries.
    O'Mahony B; Noone D; Prihodova L
    Haemophilia; 2015 Jul; 21(4):436-43. PubMed ID: 25996253
    [TBL] [Abstract][Full Text] [Related]  

  • 77. How I manage patients with inherited haemophilia A and B and factor inhibitors.
    Ljung RCR
    Br J Haematol; 2018 Feb; 180(4):501-510. PubMed ID: 29270992
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Purchasing factor concentrates in the 21st century through competitive tendering.
    Hay CR
    Haemophilia; 2013 Sep; 19(5):660-7. PubMed ID: 23711201
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hospital costs of treating haemophilic patients infected with HIV.
    Kennelly JM; Tolley KH; Ghani AC; Sabin CA; Maynard AK; Lee CA
    AIDS; 1995 Jul; 9(7):787-93. PubMed ID: 7546425
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive care of the patient with haemophilia and inhibitors undergoing surgery: practical aspects.
    Kulkarni R
    Haemophilia; 2013 Jan; 19(1):2-10. PubMed ID: 22925397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.